Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd (AUROPHARMA) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 3,94,525
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,217.60
₹-5.50 (-0.45%)
1,209.00Low
Today’s Performance
1,226.40High
1,010.00Low
52 Week’s Performance
1,356.20High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-0.45%
  • 1 Week-0.74%
  • 1 Month6.75%
  • 3 Months16.62%
  • 6 Months5.01%
  • 1 Year-2.09%
  • 3 Years37.75%
  • 5 Years6.00%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta1.10
  • 52-Week Low (₹)1,010.00
  • 52-Week High (₹)1,356.20
  • Price-to-Book (X)*2.03
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*20.78
  • Earnings Per Share (₹)58.90
  • Market Cap (₹ Cr.)*71,037.85
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions8:35IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions
View more

bt_logoFAQ's

What was Aurobindo Pharma Ltd share price previously?
Aurobindo Pharma Ltd share price was down by -0.45% from the previous closing price of ₹1,223.10.
Who are peers of Aurobindo Pharma Ltd?
The peers of Aurobindo Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Aurobindo Pharma Ltd?
The promotor/promotors of Aurobindo Pharma Ltd are Kambam Nityananda Reddy, M Madan Mohan Reddy, P V Ramprasad Reddy, Girish Paman Vanvari, P Sarath Chandra Reddy, Santanu Mukherjee, Deepali Pant Joshi, M R Kumar, Satakarni Makkapati, B Adi Reddy.
What has been 52-week high of Aurobindo Pharma Ltd stocks?
The highest price of Aurobindo Pharma Ltd stock is ₹1,356.20 in the last 52-week.
What is the share price of Aurobindo Pharma Ltd (AUROPHARMA) today on NSE?
As on Dec 05, 2025 Aurobindo Pharma Ltd (AUROPHARMA)’s share price on NSE is Rs 1217.6
What is the market cap of Aurobindo Pharma Ltd (AUROPHARMA)?
The current market capitalisation of Aurobindo Pharma Ltd (AUROPHARMA) is 71,037.85 crores
What is Aurobindo Pharma Ltd Share symbol?
The symbol of Aurobindo Pharma Ltd is AUROPHARMA.
What is the PE ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
The current PE ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 20.78.
What is the PB ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
The current PB ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 2.03.
Today’s High & Low share prices of Aurobindo Pharma Ltd (AUROPHARMA) on NSE?
Today, the share price of Aurobindo Pharma Ltd (AUROPHARMA) on NSE touched a high of Rs 1226.4 and a low of Rs 1209
What price did Aurobindo Pharma Ltd (AUROPHARMA) shares open on the NSE today?
On NSE, the share price of Aurobindo Pharma Ltd (AUROPHARMA) opened at Rs 1225
What is the 52-week high of Aurobindo Pharma Ltd (AUROPHARMA)?
The 52-week high price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 1,356.20
What is the 52-week low of Aurobindo Pharma Ltd (AUROPHARMA)?
The 52-week low price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 1,010.00

bt_logoAbout Aurobindo Pharma

Aurobindo Pharma Ltd, incorporated in the year 1986, has its registered office in Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038, 91-40-23736370, 91-40-23747340. The main industry in which Aurobindo Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Aurobindo Pharma Ltd is/are Deloitte Haskins & Sells. In the main management, M R Kumar is chairman and B Adi Reddy is the company secretary for Aurobindo Pharma Ltd.

  • KNR
    Kambam Nityananda ReddyVice Chairman & Managing Director
  • MMMR
    M Madan Mohan ReddyWhole-time Director
  • PVRR
    P V Ramprasad ReddyNon Executive Director
  • GPV
    Girish Paman VanvariIndependent Director
  • PSCR
    P Sarath Chandra ReddyNon Executive Director
  • SM
    Santanu MukherjeeIndependent Director
  • DPJ
    Deepali Pant JoshiIndependent Director
  • MRK
    M R KumarChairman & Independent Director
  • SM
    Satakarni MakkapatiNon Executive Director
  • BAR
    B Adi ReddyCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.